
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CDK5RAP1 CRISPR/Cas9 KO Plasmid (h) | sc-407278 | 20 µg | $397.00 |
CDK5RAP1 (CDK5 regulatory subunit–associated protein 1) is a radical S-adenosylmethionine enzyme localized primarily to mitochondria where it catalyzes post-transcriptional modification of mitochondrial tRNAs, supporting accurate mitochondrial translation and respiratory chain integrity. By regulating mitochondrial proteostasis and oxidative phosphorylation capacity, CDK5RAP1 influences cellular energy metabolism, redox balance, and stress-adaptive responses. Altered CDK5RAP1 activity has been linked to disrupted mitochondrial function and is frequently investigated in contexts of metabolic rewiring, hypoxia adaptation, and genome stability under oxidative stress. These pathways make CDK5RAP1 a relevant target for mechanistic studies in cancer biology and other disorders characterized by mitochondrial dysfunction.
CDK5RAP1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the CDK5RAP1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the CDK5RAP1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the CDK5RAP1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish CDK5RAP1 protein expression.
This CRISPR knockout system enables efficient generation of CDK5RAP1-deficient cell models for investigation of CDK5RAP1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.